(2R,6R)-2,6-dimethyl-1-(3-methylbutyl)-4-propan-2-ylpiperazine;N-[(4-methylcyclohexyl)methyl]-N-propan-2-yl-3-propan-2-yloxycyclobutan-1-amine;N-methyl-N-(4-methylcyclohexyl)-1-propan-2-ylpiperidin-4-amine;1-methyl-5-[4-[4-(3-methyl-2-propan-2-ylimidazol-4-yl)phenyl]phenyl]-2-propan-2-ylimidazole;N-methyl-1-propan-2-yl-N-(2-propan-2-yloxyethyl)pyrrolidin-3-amine;1-methyl-2-propan-2-yl-5-[4-(4-propan-2-ylphenyl)phenyl]pyrrole;(2-propan-2-yl-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrol-5-yl)-(4-propan-2-ylpiperazin-1-yl)methanone;1-propan-2-yl-4-[(1-propan-2-ylazetidin-3-yl)methyl]piperazine;N-propan-2-yl-N-[(1-propan-2-ylazetidin-3-yl)methyl]-3-propan-2-yloxycyclobutan-1-amine;1-propan-2-yl-4-(3-propan-2-ylcyclopentyl)piperazine;1-propan-2-yl-4-[2-(1-propan-2-ylpiperidin-4-yl)ethyl]piperazine;1-propan-2-yl-4-[(1-propan-2-ylpyrrolidin-3-yl)methoxy]piperidine;1-propan-2-yl-4-(2-propan-2-ylsulfanylethyl)piperazine

C218H400N30O5S — CID 161140098

IUPAC(2R,6R)-2,6-dimethyl-1-(3-methylbutyl)-4-propan-2-ylpiperazine;N-[(4-methylcyclohexyl)methyl]-N-propan-2-yl-3-propan-2-yloxycyclobutan-1-amine;N-methyl-N-(4-methylcyclohexyl)-1-propan-2-ylpiperidin-4-amine;1-methyl-5-[4-[4-(3-methyl-2-propan-2-ylimidazol-4-yl)phenyl]phenyl]-2-propan-2-ylimidazole;N-methyl-1-propan-2-yl-N-(2-propan-2-yloxyethyl)pyrrolidin-3-amine;1-methyl-2-propan-2-yl-5-[4-(4-propan-2-ylphenyl)phenyl]pyrrole;(2-propan-2-yl-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrol-5-yl)-(4-propan-2-ylpiperazin-1-yl)methanone;1-propan-2-yl-4-[(1-propan-2-ylazetidin-3-yl)methyl]piperazine;N-propan-2-yl-N-[(1-propan-2-ylazetidin-3-yl)methyl]-3-propan-2-yloxycyclobutan-1-amine;1-propan-2-yl-4-(3-propan-2-ylcyclopentyl)piperazine;1-propan-2-yl-4-[2-(1-propan-2-ylpiperidin-4-yl)ethyl]piperazine;1-propan-2-yl-4-[(1-propan-2-ylpyrrolidin-3-yl)methoxy]piperidine;1-propan-2-yl-4-(2-propan-2-ylsulfanylethyl)piperazine
SMILESCC(C)C1CCC(N2CCN(C(C)C)CC2)C1.CC(C)CCN1[C@H](C)CN(C(C)C)C[C@H]1C.CC(C)N1CCC(CCN2CCN(C(C)C)CC2)CC1.CC(C)N1CCC(OCC2CCN(C(C)C)C2)CC1.CC(C)N1CCN(C(=O)N2CC3CN(C(C)C)CC3C2)CC1.CC(C)N1CCN(CC2CN(C(C)C)C2)CC1.CC(C)OC1CC(N(CC2CN(C(C)C)C2)C(C)C)C1.CC(C)OCCN(C)C1CCN(C(C)C)C1.CC(C)SCCN1CCN(C(C)C)CC1.CC(C)c1ccc(-c2ccc(-c3ccc(C(C)C)n3C)cc2)cc1.CC(C)c1ncc(-c2ccc(-c3ccc(-c4cnc(C(C)C)n4C)cc3)cc2)n1C.CC1CCC(CN(C(C)C)C2CC(OC(C)C)C2)CC1.CC1CCC(N(C)C2CCN(C(C)C)CC2)CC1
InChIInChI=1S/C26H30N4.C23H27N.C18H35NO.C17H32N4O.C17H35N3.C17H34N2O.C16H32N2O.C16H32N2.C15H30N2.C14H29N3.C14H30N2.C13H28N2O.C12H26N2S/c1-17(2)25-27-15-23(29(25)5)21-11-7-19(8-12-21)20-9-13-22(14-10-20)24-16-28-26(18(3)4)30(24)6;1-16(2)18-6-8-19(9-7-18)20-10-12-21(13-11-20)23-15-14-22(17(3)4)24(23)5;1-13(2)19(12-16-8-6-15(5)7-9-16)17-10-18(11-17)20-14(3)4;1-13(2)18-5-7-19(8-6-18)17(22)21-11-15-9-20(14(3)4)10-16(15)12-21;1-15(2)19-9-6-17(7-10-19)5-8-18-11-13-20(14-12-18)16(3)4;1-12(2)18-9-15(10-18)11-19(13(3)4)16-7-17(8-16)20-14(5)6;1-13(2)17-9-6-16(7-10-17)19-12-15-5-8-18(11-15)14(3)4;1-13(2)18-11-9-16(10-12-18)17(4)15-7-5-14(3)6-8-15;1-12(2)14-5-6-15(11-14)17-9-7-16(8-10-17)13(3)4;1-12(2)16-7-5-15(6-8-16)9-14-10-17(11-14)13(3)4;1-11(2)7-8-16-13(5)9-15(12(3)4)10-14(16)6;1-11(2)15-7-6-13(10-15)14(5)8-9-16-12(3)4;1-11(2)14-7-5-13(6-8-14)9-10-15-12(3)4/h7-18H,1-6H3;6-17H,1-5H3;13-18H,6-12H2,1-5H3;13-16H,5-12H2,1-4H3;15-17H,5-14H2,1-4H3;12-17H,7-11H2,1-6H3;13-16H,5-12H2,1-4H3;13-16H,5-12H2,1-4H3;12-15H,5-11H2,1-4H3;12-14H,5-11H2,1-4H3;11-14H,7-10H2,1-6H3;11-13H,6-10H2,1-5H3;11-12H,5-10H2,1-4H3/t;;;;;;;;;;13-,14-;;/m..........1../s1
InChIKeyUNIDKJITMJZJAR-UJHDRWAOSA-N
MW3553.87 g/mol
LogP41.39
Rot. Bonds59

About (2R,6R)-2,6-dimethyl-1-(3-methylbutyl)-4-propan-2-ylpiperazine;N-[(4-methylcyclohexyl)methyl]-N-propan-2-yl-3-propan-2-yloxycyclobutan-1-amine;N-methyl-N-(4-methylcyclohexyl)-1-propan-2-ylpiperidin-4-amine;1-methyl-5-[4-[4-(3-methyl-2-propan-2-ylimidazol-4-yl)phenyl]phenyl]-2-propan-2-ylimidazole;N-methyl-1-propan-2-yl-N-(2-propan-2-yloxyethyl)pyrrolidin-3-amine;1-methyl-2-propan-2-yl-5-[4-(4-propan-2-ylphenyl)phenyl]pyrrole;(2-propan-2-yl-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrol-5-yl)-(4-propan-2-ylpiperazin-1-yl)methanone;1-propan-2-yl-4-[(1-propan-2-ylazetidin-3-yl)methyl]piperazine;N-propan-2-yl-N-[(1-propan-2-ylazetidin-3-yl)methyl]-3-propan-2-yloxycyclobutan-1-amine;1-propan-2-yl-4-(3-propan-2-ylcyclopentyl)piperazine;1-propan-2-yl-4-[2-(1-propan-2-ylpiperidin-4-yl)ethyl]piperazine;1-propan-2-yl-4-[(1-propan-2-ylpyrrolidin-3-yl)methoxy]piperidine;1-propan-2-yl-4-(2-propan-2-ylsulfanylethyl)piperazine

(2R,6R)-2,6-dimethyl-1-(3-methylbutyl)-4-propan-2-ylpiperazine;N-[(4-methylcyclohexyl)methyl]-N-propan-2-yl-3-propan-2-yloxycyclobutan-1-amine;N-methyl-N-(4-methylcyclohexyl)-1-propan-2-ylpiperidin-4-amine;1-methyl-5-[4-[4-(3-methyl-2-propan-2-ylimidazol-4-yl)phenyl]phenyl]-2-propan-2-ylimidazole;N-methyl-1-propan-2-yl-N-(2-propan-2-yloxyethyl)pyrrolidin-3-amine;1-methyl-2-propan-2-yl-5-[4-(4-propan-2-ylphenyl)phenyl]pyrrole;(2-propan-2-yl-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrol-5-yl)-(4-propan-2-ylpiperazin-1-yl)methanone;1-propan-2-yl-4-[(1-propan-2-ylazetidin-3-yl)methyl]piperazine;N-propan-2-yl-N-[(1-propan-2-ylazetidin-3-yl)methyl]-3-propan-2-yloxycyclobutan-1-amine;1-propan-2-yl-4-(3-propan-2-ylcyclopentyl)piperazine;1-propan-2-yl-4-[2-(1-propan-2-ylpiperidin-4-yl)ethyl]piperazine;1-propan-2-yl-4-[(1-propan-2-ylpyrrolidin-3-yl)methoxy]piperidine;1-propan-2-yl-4-(2-propan-2-ylsulfanylethyl)piperazine (PubChem CID 161140098) has the molecular formula C218H400N30O5S and a molecular weight of 3553.87 g/mol. Its IUPAC name is (2R,6R)-2,6-dimethyl-1-(3-methylbutyl)-4-propan-2-ylpiperazine;N-[(4-methylcyclohexyl)methyl]-N-propan-2-yl-3-propan-2-yloxycyclobutan-1-amine;N-methyl-N-(4-methylcyclohexyl)-1-propan-2-ylpiperidin-4-amine;1-methyl-5-[4-[4-(3-methyl-2-propan-2-ylimidazol-4-yl)phenyl]phenyl]-2-propan-2-ylimidazole;N-methyl-1-propan-2-yl-N-(2-propan-2-yloxyethyl)pyrrolidin-3-amine;1-methyl-2-propan-2-yl-5-[4-(4-propan-2-ylphenyl)phenyl]pyrrole;(2-propan-2-yl-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrol-5-yl)-(4-propan-2-ylpiperazin-1-yl)methanone;1-propan-2-yl-4-[(1-propan-2-ylazetidin-3-yl)methyl]piperazine;N-propan-2-yl-N-[(1-propan-2-ylazetidin-3-yl)methyl]-3-propan-2-yloxycyclobutan-1-amine;1-propan-2-yl-4-(3-propan-2-ylcyclopentyl)piperazine;1-propan-2-yl-4-[2-(1-propan-2-ylpiperidin-4-yl)ethyl]piperazine;1-propan-2-yl-4-[(1-propan-2-ylpyrrolidin-3-yl)methoxy]piperidine;1-propan-2-yl-4-(2-propan-2-ylsulfanylethyl)piperazine.

Molecular Properties

Compound Name(2R,6R)-2,6-dimethyl-1-(3-methylbutyl)-4-propan-2-ylpiperazine;N-[(4-methylcyclohexyl)methyl]-N-propan-2-yl-3-propan-2-yloxycyclobutan-1-amine;N-methyl-N-(4-methylcyclohexyl)-1-propan-2-ylpiperidin-4-amine;1-methyl-5-[4-[4-(3-methyl-2-propan-2-ylimidazol-4-yl)phenyl]phenyl]-2-propan-2-ylimidazole;N-methyl-1-propan-2-yl-N-(2-propan-2-yloxyethyl)pyrrolidin-3-amine;1-methyl-2-propan-2-yl-5-[4-(4-propan-2-ylphenyl)phenyl]pyrrole;(2-propan-2-yl-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrol-5-yl)-(4-propan-2-ylpiperazin-1-yl)methanone;1-propan-2-yl-4-[(1-propan-2-ylazetidin-3-yl)methyl]piperazine;N-propan-2-yl-N-[(1-propan-2-ylazetidin-3-yl)methyl]-3-propan-2-yloxycyclobutan-1-amine;1-propan-2-yl-4-(3-propan-2-ylcyclopentyl)piperazine;1-propan-2-yl-4-[2-(1-propan-2-ylpiperidin-4-yl)ethyl]piperazine;1-propan-2-yl-4-[(1-propan-2-ylpyrrolidin-3-yl)methoxy]piperidine;1-propan-2-yl-4-(2-propan-2-ylsulfanylethyl)piperazine
PubChem CID161140098
Molecular FormulaC218H400N30O5S
Molecular Weight3553.87 g/mol
Exact Mass3551.17
IUPAC Name(2R,6R)-2,6-dimethyl-1-(3-methylbutyl)-4-propan-2-ylpiperazine;N-[(4-methylcyclohexyl)methyl]-N-propan-2-yl-3-propan-2-yloxycyclobutan-1-amine;N-methyl-N-(4-methylcyclohexyl)-1-propan-2-ylpiperidin-4-amine;1-methyl-5-[4-[4-(3-methyl-2-propan-2-ylimidazol-4-yl)phenyl]phenyl]-2-propan-2-ylimidazole;N-methyl-1-propan-2-yl-N-(2-propan-2-yloxyethyl)pyrrolidin-3-amine;1-methyl-2-propan-2-yl-5-[4-(4-propan-2-ylphenyl)phenyl]pyrrole;(2-propan-2-yl-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrol-5-yl)-(4-propan-2-ylpiperazin-1-yl)methanone;1-propan-2-yl-4-[(1-propan-2-ylazetidin-3-yl)methyl]piperazine;N-propan-2-yl-N-[(1-propan-2-ylazetidin-3-yl)methyl]-3-propan-2-yloxycyclobutan-1-amine;1-propan-2-yl-4-(3-propan-2-ylcyclopentyl)piperazine;1-propan-2-yl-4-[2-(1-propan-2-ylpiperidin-4-yl)ethyl]piperazine;1-propan-2-yl-4-[(1-propan-2-ylpyrrolidin-3-yl)methoxy]piperidine;1-propan-2-yl-4-(2-propan-2-ylsulfanylethyl)piperazine
SMILESCC(C)C1CCC(N2CCN(C(C)C)CC2)C1.CC(C)CCN1[C@H](C)CN(C(C)C)C[C@H]1C.CC(C)N1CCC(CCN2CCN(C(C)C)CC2)CC1.CC(C)N1CCC(OCC2CCN(C(C)C)C2)CC1.CC(C)N1CCN(C(=O)N2CC3CN(C(C)C)CC3C2)CC1.CC(C)N1CCN(CC2CN(C(C)C)C2)CC1.CC(C)OC1CC(N(CC2CN(C(C)C)C2)C(C)C)C1.CC(C)OCCN(C)C1CCN(C(C)C)C1.CC(C)SCCN1CCN(C(C)C)CC1.CC(C)c1ccc(-c2ccc(-c3ccc(C(C)C)n3C)cc2)cc1.CC(C)c1ncc(-c2ccc(-c3ccc(-c4cnc(C(C)C)n4C)cc3)cc2)n1C.CC1CCC(CN(C(C)C)C2CC(OC(C)C)C2)CC1.CC1CCC(N(C)C2CCN(C(C)C)CC2)CC1
InChIInChI=1S/C26H30N4.C23H27N.C18H35NO.C17H32N4O.C17H35N3.C17H34N2O.C16H32N2O.C16H32N2.C15H30N2.C14H29N3.C14H30N2.C13H28N2O.C12H26N2S/c1-17(2)25-27-15-23(29(25)5)21-11-7-19(8-12-21)20-9-13-22(14-10-20)24-16-28-26(18(3)4)30(24)6;1-16(2)18-6-8-19(9-7-18)20-10-12-21(13-11-20)23-15-14-22(17(3)4)24(23)5;1-13(2)19(12-16-8-6-15(5)7-9-16)17-10-18(11-17)20-14(3)4;1-13(2)18-5-7-19(8-6-18)17(22)21-11-15-9-20(14(3)4)10-16(15)12-21;1-15(2)19-9-6-17(7-10-19)5-8-18-11-13-20(14-12-18)16(3)4;1-12(2)18-9-15(10-18)11-19(13(3)4)16-7-17(8-16)20-14(5)6;1-13(2)17-9-6-16(7-10-17)19-12-15-5-8-18(11-15)14(3)4;1-13(2)18-11-9-16(10-12-18)17(4)15-7-5-14(3)6-8-15;1-12(2)14-5-6-15(11-14)17-9-7-16(8-10-17)13(3)4;1-12(2)16-7-5-15(6-8-16)9-14-10-17(11-14)13(3)4;1-11(2)7-8-16-13(5)9-15(12(3)4)10-14(16)6;1-11(2)15-7-6-13(10-15)14(5)8-9-16-12(3)4;1-11(2)14-7-5-13(6-8-14)9-10-15-12(3)4/h7-18H,1-6H3;6-17H,1-5H3;13-18H,6-12H2,1-5H3;13-16H,5-12H2,1-4H3;15-17H,5-14H2,1-4H3;12-17H,7-11H2,1-6H3;13-16H,5-12H2,1-4H3;13-16H,5-12H2,1-4H3;12-15H,5-11H2,1-4H3;12-14H,5-11H2,1-4H3;11-14H,7-10H2,1-6H3;11-13H,6-10H2,1-5H3;11-12H,5-10H2,1-4H3/t;;;;;;;;;;13-,14-;;/m..........1../s1
InChIKeyUNIDKJITMJZJAR-UJHDRWAOSA-N
XLogP41.39
TPSA175.56 Ų
H-Bond Donors
H-Bond Acceptors34
Rotatable Bonds59
Heavy Atoms254
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5003553.87
LogP ≤ 541.39
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1034

Analyze (2R,6R)-2,6-dimethyl-1-(3-methylbutyl)-4-propan-2-ylpiperazine;N-[(4-methylcyclohexyl)methyl]-N-propan-2-yl-3-propan-2-yloxycyclobutan-1-amine;N-methyl-N-(4-methylcyclohexyl)-1-propan-2-ylpiperidin-4-amine;1-methyl-5-[4-[4-(3-methyl-2-propan-2-ylimidazol-4-yl)phenyl]phenyl]-2-propan-2-ylimidazole;N-methyl-1-propan-2-yl-N-(2-propan-2-yloxyethyl)pyrrolidin-3-amine;1-methyl-2-propan-2-yl-5-[4-(4-propan-2-ylphenyl)phenyl]pyrrole;(2-propan-2-yl-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrol-5-yl)-(4-propan-2-ylpiperazin-1-yl)methanone;1-propan-2-yl-4-[(1-propan-2-ylazetidin-3-yl)methyl]piperazine;N-propan-2-yl-N-[(1-propan-2-ylazetidin-3-yl)methyl]-3-propan-2-yloxycyclobutan-1-amine;1-propan-2-yl-4-(3-propan-2-ylcyclopentyl)piperazine;1-propan-2-yl-4-[2-(1-propan-2-ylpiperidin-4-yl)ethyl]piperazine;1-propan-2-yl-4-[(1-propan-2-ylpyrrolidin-3-yl)methoxy]piperidine;1-propan-2-yl-4-(2-propan-2-ylsulfanylethyl)piperazine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of (2R,6R)-2,6-dimethyl-1-(3-methylbutyl)-4-propan-2-ylpiperazine;N-[(4-methylcyclohexyl)methyl]-N-propan-2-yl-3-propan-2-yloxycyclobutan-1-amine;N-methyl-N-(4-methylcyclohexyl)-1-propan-2-ylpiperidin-4-amine;1-methyl-5-[4-[4-(3-methyl-2-propan-2-ylimidazol-4-yl)phenyl]phenyl]-2-propan-2-ylimidazole;N-methyl-1-propan-2-yl-N-(2-propan-2-yloxyethyl)pyrrolidin-3-amine;1-methyl-2-propan-2-yl-5-[4-(4-propan-2-ylphenyl)phenyl]pyrrole;(2-propan-2-yl-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrol-5-yl)-(4-propan-2-ylpiperazin-1-yl)methanone;1-propan-2-yl-4-[(1-propan-2-ylazetidin-3-yl)methyl]piperazine;N-propan-2-yl-N-[(1-propan-2-ylazetidin-3-yl)methyl]-3-propan-2-yloxycyclobutan-1-amine;1-propan-2-yl-4-(3-propan-2-ylcyclopentyl)piperazine;1-propan-2-yl-4-[2-(1-propan-2-ylpiperidin-4-yl)ethyl]piperazine;1-propan-2-yl-4-[(1-propan-2-ylpyrrolidin-3-yl)methoxy]piperidine;1-propan-2-yl-4-(2-propan-2-ylsulfanylethyl)piperazine?
The IUPAC name of (2R,6R)-2,6-dimethyl-1-(3-methylbutyl)-4-propan-2-ylpiperazine;N-[(4-methylcyclohexyl)methyl]-N-propan-2-yl-3-propan-2-yloxycyclobutan-1-amine;N-methyl-N-(4-methylcyclohexyl)-1-propan-2-ylpiperidin-4-amine;1-methyl-5-[4-[4-(3-methyl-2-propan-2-ylimidazol-4-yl)phenyl]phenyl]-2-propan-2-ylimidazole;N-methyl-1-propan-2-yl-N-(2-propan-2-yloxyethyl)pyrrolidin-3-amine;1-methyl-2-propan-2-yl-5-[4-(4-propan-2-ylphenyl)phenyl]pyrrole;(2-propan-2-yl-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrol-5-yl)-(4-propan-2-ylpiperazin-1-yl)methanone;1-propan-2-yl-4-[(1-propan-2-ylazetidin-3-yl)methyl]piperazine;N-propan-2-yl-N-[(1-propan-2-ylazetidin-3-yl)methyl]-3-propan-2-yloxycyclobutan-1-amine;1-propan-2-yl-4-(3-propan-2-ylcyclopentyl)piperazine;1-propan-2-yl-4-[2-(1-propan-2-ylpiperidin-4-yl)ethyl]piperazine;1-propan-2-yl-4-[(1-propan-2-ylpyrrolidin-3-yl)methoxy]piperidine;1-propan-2-yl-4-(2-propan-2-ylsulfanylethyl)piperazine (CID 161140098) is (2R,6R)-2,6-dimethyl-1-(3-methylbutyl)-4-propan-2-ylpiperazine;N-[(4-methylcyclohexyl)methyl]-N-propan-2-yl-3-propan-2-yloxycyclobutan-1-amine;N-methyl-N-(4-methylcyclohexyl)-1-propan-2-ylpiperidin-4-amine;1-methyl-5-[4-[4-(3-methyl-2-propan-2-ylimidazol-4-yl)phenyl]phenyl]-2-propan-2-ylimidazole;N-methyl-1-propan-2-yl-N-(2-propan-2-yloxyethyl)pyrrolidin-3-amine;1-methyl-2-propan-2-yl-5-[4-(4-propan-2-ylphenyl)phenyl]pyrrole;(2-propan-2-yl-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrol-5-yl)-(4-propan-2-ylpiperazin-1-yl)methanone;1-propan-2-yl-4-[(1-propan-2-ylazetidin-3-yl)methyl]piperazine;N-propan-2-yl-N-[(1-propan-2-ylazetidin-3-yl)methyl]-3-propan-2-yloxycyclobutan-1-amine;1-propan-2-yl-4-(3-propan-2-ylcyclopentyl)piperazine;1-propan-2-yl-4-[2-(1-propan-2-ylpiperidin-4-yl)ethyl]piperazine;1-propan-2-yl-4-[(1-propan-2-ylpyrrolidin-3-yl)methoxy]piperidine;1-propan-2-yl-4-(2-propan-2-ylsulfanylethyl)piperazine.
What is the SMILES notation for (2R,6R)-2,6-dimethyl-1-(3-methylbutyl)-4-propan-2-ylpiperazine;N-[(4-methylcyclohexyl)methyl]-N-propan-2-yl-3-propan-2-yloxycyclobutan-1-amine;N-methyl-N-(4-methylcyclohexyl)-1-propan-2-ylpiperidin-4-amine;1-methyl-5-[4-[4-(3-methyl-2-propan-2-ylimidazol-4-yl)phenyl]phenyl]-2-propan-2-ylimidazole;N-methyl-1-propan-2-yl-N-(2-propan-2-yloxyethyl)pyrrolidin-3-amine;1-methyl-2-propan-2-yl-5-[4-(4-propan-2-ylphenyl)phenyl]pyrrole;(2-propan-2-yl-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrol-5-yl)-(4-propan-2-ylpiperazin-1-yl)methanone;1-propan-2-yl-4-[(1-propan-2-ylazetidin-3-yl)methyl]piperazine;N-propan-2-yl-N-[(1-propan-2-ylazetidin-3-yl)methyl]-3-propan-2-yloxycyclobutan-1-amine;1-propan-2-yl-4-(3-propan-2-ylcyclopentyl)piperazine;1-propan-2-yl-4-[2-(1-propan-2-ylpiperidin-4-yl)ethyl]piperazine;1-propan-2-yl-4-[(1-propan-2-ylpyrrolidin-3-yl)methoxy]piperidine;1-propan-2-yl-4-(2-propan-2-ylsulfanylethyl)piperazine?
The canonical SMILES for (2R,6R)-2,6-dimethyl-1-(3-methylbutyl)-4-propan-2-ylpiperazine;N-[(4-methylcyclohexyl)methyl]-N-propan-2-yl-3-propan-2-yloxycyclobutan-1-amine;N-methyl-N-(4-methylcyclohexyl)-1-propan-2-ylpiperidin-4-amine;1-methyl-5-[4-[4-(3-methyl-2-propan-2-ylimidazol-4-yl)phenyl]phenyl]-2-propan-2-ylimidazole;N-methyl-1-propan-2-yl-N-(2-propan-2-yloxyethyl)pyrrolidin-3-amine;1-methyl-2-propan-2-yl-5-[4-(4-propan-2-ylphenyl)phenyl]pyrrole;(2-propan-2-yl-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrol-5-yl)-(4-propan-2-ylpiperazin-1-yl)methanone;1-propan-2-yl-4-[(1-propan-2-ylazetidin-3-yl)methyl]piperazine;N-propan-2-yl-N-[(1-propan-2-ylazetidin-3-yl)methyl]-3-propan-2-yloxycyclobutan-1-amine;1-propan-2-yl-4-(3-propan-2-ylcyclopentyl)piperazine;1-propan-2-yl-4-[2-(1-propan-2-ylpiperidin-4-yl)ethyl]piperazine;1-propan-2-yl-4-[(1-propan-2-ylpyrrolidin-3-yl)methoxy]piperidine;1-propan-2-yl-4-(2-propan-2-ylsulfanylethyl)piperazine is CC(C)C1CCC(N2CCN(C(C)C)CC2)C1.CC(C)CCN1[C@H](C)CN(C(C)C)C[C@H]1C.CC(C)N1CCC(CCN2CCN(C(C)C)CC2)CC1.CC(C)N1CCC(OCC2CCN(C(C)C)C2)CC1.CC(C)N1CCN(C(=O)N2CC3CN(C(C)C)CC3C2)CC1.CC(C)N1CCN(CC2CN(C(C)C)C2)CC1.CC(C)OC1CC(N(CC2CN(C(C)C)C2)C(C)C)C1.CC(C)OCCN(C)C1CCN(C(C)C)C1.CC(C)SCCN1CCN(C(C)C)CC1.CC(C)c1ccc(-c2ccc(-c3ccc(C(C)C)n3C)cc2)cc1.CC(C)c1ncc(-c2ccc(-c3ccc(-c4cnc(C(C)C)n4C)cc3)cc2)n1C.CC1CCC(CN(C(C)C)C2CC(OC(C)C)C2)CC1.CC1CCC(N(C)C2CCN(C(C)C)CC2)CC1.
What is the InChIKey of (2R,6R)-2,6-dimethyl-1-(3-methylbutyl)-4-propan-2-ylpiperazine;N-[(4-methylcyclohexyl)methyl]-N-propan-2-yl-3-propan-2-yloxycyclobutan-1-amine;N-methyl-N-(4-methylcyclohexyl)-1-propan-2-ylpiperidin-4-amine;1-methyl-5-[4-[4-(3-methyl-2-propan-2-ylimidazol-4-yl)phenyl]phenyl]-2-propan-2-ylimidazole;N-methyl-1-propan-2-yl-N-(2-propan-2-yloxyethyl)pyrrolidin-3-amine;1-methyl-2-propan-2-yl-5-[4-(4-propan-2-ylphenyl)phenyl]pyrrole;(2-propan-2-yl-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrol-5-yl)-(4-propan-2-ylpiperazin-1-yl)methanone;1-propan-2-yl-4-[(1-propan-2-ylazetidin-3-yl)methyl]piperazine;N-propan-2-yl-N-[(1-propan-2-ylazetidin-3-yl)methyl]-3-propan-2-yloxycyclobutan-1-amine;1-propan-2-yl-4-(3-propan-2-ylcyclopentyl)piperazine;1-propan-2-yl-4-[2-(1-propan-2-ylpiperidin-4-yl)ethyl]piperazine;1-propan-2-yl-4-[(1-propan-2-ylpyrrolidin-3-yl)methoxy]piperidine;1-propan-2-yl-4-(2-propan-2-ylsulfanylethyl)piperazine?
The InChIKey is UNIDKJITMJZJAR-UJHDRWAOSA-N. The full InChI is InChI=1S/C26H30N4.C23H27N.C18H35NO.C17H32N4O.C17H35N3.C17H34N2O.C16H32N2O.C16H32N2.C15H30N2.C14H29N3.C14H30N2.C13H28N2O.C12H26N2S/c1-17(2)25-27-15-23(29(25)5)21-11-7-19(8-12-21)20-9-13-22(14-10-20)24-16-28-26(18(3)4)30(24)6;1-16(2)18-6-8-19(9-7-18)20-10-12-21(13-11-20)23-15-14-22(17(3)4)24(23)5;1-13(2)19(12-16-8-6-15(5)7-9-16)17-10-18(11-17)20-14(3)4;1-13(2)18-5-7-19(8-6-18)17(22)21-11-15-9-20(14(3)4)10-16(15)12-21;1-15(2)19-9-6-17(7-10-19)5-8-18-11-13-20(14-12-18)16(3)4;1-12(2)18-9-15(10-18)11-19(13(3)4)16-7-17(8-16)20-14(5)6;1-13(2)17-9-6-16(7-10-17)19-12-15-5-8-18(11-15)14(3)4;1-13(2)18-11-9-16(10-12-18)17(4)15-7-5-14(3)6-8-15;1-12(2)14-5-6-15(11-14)17-9-7-16(8-10-17)13(3)4;1-12(2)16-7-5-15(6-8-16)9-14-10-17(11-14)13(3)4;1-11(2)7-8-16-13(5)9-15(12(3)4)10-14(16)6;1-11(2)15-7-6-13(10-15)14(5)8-9-16-12(3)4;1-11(2)14-7-5-13(6-8-14)9-10-15-12(3)4/h7-18H,1-6H3;6-17H,1-5H3;13-18H,6-12H2,1-5H3;13-16H,5-12H2,1-4H3;15-17H,5-14H2,1-4H3;12-17H,7-11H2,1-6H3;13-16H,5-12H2,1-4H3;13-16H,5-12H2,1-4H3;12-15H,5-11H2,1-4H3;12-14H,5-11H2,1-4H3;11-14H,7-10H2,1-6H3;11-13H,6-10H2,1-5H3;11-12H,5-10H2,1-4H3/t;;;;;;;;;;13-,14-;;/m..........1../s1.
What are the key properties of (2R,6R)-2,6-dimethyl-1-(3-methylbutyl)-4-propan-2-ylpiperazine;N-[(4-methylcyclohexyl)methyl]-N-propan-2-yl-3-propan-2-yloxycyclobutan-1-amine;N-methyl-N-(4-methylcyclohexyl)-1-propan-2-ylpiperidin-4-amine;1-methyl-5-[4-[4-(3-methyl-2-propan-2-ylimidazol-4-yl)phenyl]phenyl]-2-propan-2-ylimidazole;N-methyl-1-propan-2-yl-N-(2-propan-2-yloxyethyl)pyrrolidin-3-amine;1-methyl-2-propan-2-yl-5-[4-(4-propan-2-ylphenyl)phenyl]pyrrole;(2-propan-2-yl-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrol-5-yl)-(4-propan-2-ylpiperazin-1-yl)methanone;1-propan-2-yl-4-[(1-propan-2-ylazetidin-3-yl)methyl]piperazine;N-propan-2-yl-N-[(1-propan-2-ylazetidin-3-yl)methyl]-3-propan-2-yloxycyclobutan-1-amine;1-propan-2-yl-4-(3-propan-2-ylcyclopentyl)piperazine;1-propan-2-yl-4-[2-(1-propan-2-ylpiperidin-4-yl)ethyl]piperazine;1-propan-2-yl-4-[(1-propan-2-ylpyrrolidin-3-yl)methoxy]piperidine;1-propan-2-yl-4-(2-propan-2-ylsulfanylethyl)piperazine?
(2R,6R)-2,6-dimethyl-1-(3-methylbutyl)-4-propan-2-ylpiperazine;N-[(4-methylcyclohexyl)methyl]-N-propan-2-yl-3-propan-2-yloxycyclobutan-1-amine;N-methyl-N-(4-methylcyclohexyl)-1-propan-2-ylpiperidin-4-amine;1-methyl-5-[4-[4-(3-methyl-2-propan-2-ylimidazol-4-yl)phenyl]phenyl]-2-propan-2-ylimidazole;N-methyl-1-propan-2-yl-N-(2-propan-2-yloxyethyl)pyrrolidin-3-amine;1-methyl-2-propan-2-yl-5-[4-(4-propan-2-ylphenyl)phenyl]pyrrole;(2-propan-2-yl-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrol-5-yl)-(4-propan-2-ylpiperazin-1-yl)methanone;1-propan-2-yl-4-[(1-propan-2-ylazetidin-3-yl)methyl]piperazine;N-propan-2-yl-N-[(1-propan-2-ylazetidin-3-yl)methyl]-3-propan-2-yloxycyclobutan-1-amine;1-propan-2-yl-4-(3-propan-2-ylcyclopentyl)piperazine;1-propan-2-yl-4-[2-(1-propan-2-ylpiperidin-4-yl)ethyl]piperazine;1-propan-2-yl-4-[(1-propan-2-ylpyrrolidin-3-yl)methoxy]piperidine;1-propan-2-yl-4-(2-propan-2-ylsulfanylethyl)piperazine has a molecular weight of 3553.87 g/mol, XLogP of 41.39, 59 rotatable bonds, 0 hydrogen bond donors, and 34 hydrogen bond acceptors.
Where does this data come from?
All data for (2R,6R)-2,6-dimethyl-1-(3-methylbutyl)-4-propan-2-ylpiperazine;N-[(4-methylcyclohexyl)methyl]-N-propan-2-yl-3-propan-2-yloxycyclobutan-1-amine;N-methyl-N-(4-methylcyclohexyl)-1-propan-2-ylpiperidin-4-amine;1-methyl-5-[4-[4-(3-methyl-2-propan-2-ylimidazol-4-yl)phenyl]phenyl]-2-propan-2-ylimidazole;N-methyl-1-propan-2-yl-N-(2-propan-2-yloxyethyl)pyrrolidin-3-amine;1-methyl-2-propan-2-yl-5-[4-(4-propan-2-ylphenyl)phenyl]pyrrole;(2-propan-2-yl-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrol-5-yl)-(4-propan-2-ylpiperazin-1-yl)methanone;1-propan-2-yl-4-[(1-propan-2-ylazetidin-3-yl)methyl]piperazine;N-propan-2-yl-N-[(1-propan-2-ylazetidin-3-yl)methyl]-3-propan-2-yloxycyclobutan-1-amine;1-propan-2-yl-4-(3-propan-2-ylcyclopentyl)piperazine;1-propan-2-yl-4-[2-(1-propan-2-ylpiperidin-4-yl)ethyl]piperazine;1-propan-2-yl-4-[(1-propan-2-ylpyrrolidin-3-yl)methoxy]piperidine;1-propan-2-yl-4-(2-propan-2-ylsulfanylethyl)piperazine is sourced from PubChem (CID 161140098), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).